Table 1 Patient, brain metastases, and fSRS characteristics
n | (%) | ||
|---|---|---|---|
Patient characteristics | |||
Total | 115 | ||
Age (years) | Median (range) | 66 (22–85) | |
22–65 | 56 | (48.7) | |
> 65 | 59 | (51.3) | |
Sex | Male | 55 | (47.8) |
Female | 60 | (52.2) | |
PS | 0 | 70 | (60.9) |
1 | 34 | (29.6) | |
2 | 10 | (8.7) | |
3 | 1 | (0.9) | |
Primary cancer | Lung | 71 | (61.7) |
Breast | 14 | (12.2) | |
GI | 6 | (5.2) | |
Kidney | 3 | (2.6) | |
Melanoma | 5 | (4.3) | |
Others | 16 | (13.9) | |
Brain metastases and fSRS characteristics | |||
Total | 241 | ||
Prescription dose | 30 Gy/5 fr | 28 | (11.6) |
35 Gy/5 fr | 213 | (88.4) | |
Each GTV (cc) | Median (range) | 1.1 (0.3–33.1) | |
0.3–1 | 116 | (48.1) | |
> 1–4 | 70 | (29.0) | |
> 4 | 55 | (22.8) | |